Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer
Background. Colorectal cancer (CRC) is the third most common tumor worldwide. Aberrant N6-methyladenosine (m6A) modification can influence the progress of the CRC. Additionally, long noncoding RNA (lncRNA) plays a critical role in CRC and has a close relationship with m6A modification. However, the...
Guardado en:
Autores principales: | Zhan Zhao, Ya-bing Yang, Xin-yuan Li, Xu-Guang Li, Xiao-dong Chu, Zheng-bin Lin, Yi-ran Zhang, Yan-guan Guo, Hui Ding, Yun-long Pan, Liang Wang, Jing-hua Pan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9544ac3a6e8b402daca3f56ff3980d22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer
por: Bin Ma, et al.
Publicado: (2021) -
Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Chengyin Weng, et al.
Publicado: (2021) -
Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021) -
The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Haixiu Yang, et al.
Publicado: (2017) -
A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Mei Chen, et al.
Publicado: (2021)